Indivior Pharmaceuticals (INDV) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Indivior Pharmaceuticals (INDV) is Moderate Outperform.

The composite score behind that read is +0.24, weighing +0.36 of bullish evidence against -0.02 bearish.

Indivior Pharmaceuticals last closed at $35.99, +0.78% on the session.

Against the IVW growth benchmark the position is -0.14% over the forecast window.

The read is built from 12 underlying insights — 9 bullish and 3 bearish.

Agreement across those insights is 75%.

Indivior Pharmaceuticals has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Indivior Pharmaceuticals in the 71st percentile on valuation and the 5th percentile on return on equity, where 100 is best.

Indivior Pharmaceuticals is classified under Health Care / Pharmaceuticals, with a market capitalisation of $4.21B.

StockMap tracks Indivior Pharmaceuticals as the 26th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Indivior Pharmaceuticals ranks 5th of 128 in the group, against a group median of -0.24.